Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
AZD8055 | mTOR Pathway Inhibitor | STEMCELL Technologies
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive ...
AZD8055 is an ATP-competitive mTOR kinase inhibitor. A, chemical ...
AZD8055 inhibits mTOR, cap-dependent protein translation and elicits a ...
AZD8055 blocks radiation-induced mTOR phosphorylation and sensitizes ...
AZD8055 inhibits T cell IFNγ production at day 10 posttransplant ...
AZD8055 inhibits mTORC1 and mTORC2 activation simultaneously and ...
AZD8055 prolongs allograft survival and enhances graft-infiltrating ...
AZD8055 inhibits protein synthesis and up-regulates phosphorylation of ...
Antiproliferative effect of the Upadacitinib and AZD8055 combination on ...
AZD8055 inhibited cell viability and enhanced IR-induced cell growth ...
AZD8055 improves muscle mass and reduces abnormal desmin accumulation ...
AZD8055 and bromodomain inhibitors have a synergic effect on ...
AZD8055 differentially affects p-Akt Thr308 and p-AS160 in vivo (A,B ...
(PDF) AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP ...
AZD8055 - Potent mTOR Kinase Inhibitor | APExBIO
The combination of DT2216 and AZD8055 has stronger antitumor responses ...
Comparison of RAD001 and AZD8055 effect on cell growth and mTORC1/2 ...
AZD8055 inhibits protein translation in AML cells. (a) 7mGTP affinity ...
AZD8055 inhibits the protein level of intracellular PPARγ, LPIN1 ...
Inhibition of mTOR Kinase by AZD8055 Can Antagonize Chemotherapy ...
AZD8055 inhibits the activity of the mTOR signaling pathway. Western ...
The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in ...
AZD8055 Exerts Antitumor Effects on Colon Cancer Cells by Inhibiting ...
AZD8055 inhibits cell proliferation of primary bovine mammary ...
AZD8055 inhibits glycolysis of human cervical cancer HeLa cells. (A ...
AZD8055 treatment suppresses the expression of pro-inflammatory ...
AZD8055 inhibits the proliferation and differentiation of naive CD4+ T ...
Differences in the antiproliferative capacity of AZD8055 and rapamycin ...
mTOR inhibitor AZD8055 impedes SNHG3-mediated PTC cell growth ...
Summary of drug interaction for the combination of AZD8055 and azoles ...
AZD8055 and OSI-027 triggered apoptosis and PUMA induction in colon ...
AZD8055 inhibits cell proliferation in human cervical cancer HeLa ...
AZD8055 induces whole-body insulin resistance and impairs mTOR ...
Effect of everolimus and AZD8055 on HCC cell proliferation and mTORC1/2 ...
AZD8055 impairs cell lines proliferation. Cells were treated with ...
AZD8055 inhibits cell growth by blocking p-mTOR S 2481 /p-AKT S 473 ...
Incubation with AZD8055 or Torin-1 inhibits cell migration of ...
Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer ...
AZD8055 CAS#: 1009298-09-2
An mTOR inhibitor AZD8055 preferentially inhibited proliferation and ...
Effect of AZD8055 on proliferation and viability in TamR and MCF7-X ...
Combination treatment with ABT-263 and the TORC1/2 inhibitor AZD8055 ...
AZD8055 selectively triggers apoptosis in XL413-induced senescent ...
AZD8055 impairs cell cycle progression in STS2T and 90-8 cell linesCell ...
AZD8055 | mTOR Inhibitor | CAS 1009298-09-2 | Selleck Chemicals
AZD8055 and Torin-1 show an inhibitory effect on survival of primary ...
µmol/l AZD8055 induces autophagy in h838 cells. Acridine staining (A ...
AZD8055 enhanced IR-induced G2/M cell cycle arrest and apoptosis. (A ...
AZD8055 | CAS 1009298-09-2 | SCBT - Santa Cruz Biotechnology
Figure 1 from mTOR kinase inhibitor AZD8055 enhances the ...
mTOR kinase inhibitor AZD8055 enhances the immunotherapeutic activity ...
AZD8055 Supplier | CAS 1009298-09-2 | Focus Biomolecules
Figure 1 from The mTOR inhibitor AZD8055 inhibits proliferation and ...
Schematic representation of AZD8055/OSI-027 induced apoptotic pathway ...
美国APExBIO中文官网 - AZD8055|MTOR inhibitor|CAS# 1009298-09-2
Adenosine triphosphate-competitive mTOR inhibition suppresses T cell ...
AZD8055, an mTOR kinase inhibitor, shows in vitro and in vivo ...
An mTOR inhibitor discovery system using drug-sensitized yeast ...
A, the AZD8055/selumetinib combination cooperatively suppressed 4E-BP1 ...
DT2216+AZD8055 combination synergistically kills BCL-X L /MCL-1 ...
Adenosine Triphosphate-Competitive mTOR Inhibitors: A New Class of ...
ATP-competitive inhibition of mTOR and mTORC1 knockout attenuates ...
In vitro transport and in vivo pharmacokinetics of AZD8055. A ...
Oncology Reports
Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor ...
What is the Rapamycin Dose / Dosage for Anti-Aging or Longevity ...
JCI - mTORC2 regulates renal tubule sodium uptake by promoting ENaC ...
Adenosine Triphosphate‐Competitive mTOR Inhibitors: A New Class of ...
- MedCrave online
Oncology Letters
A pharmacokinetic–pharmacodynamic model predicting tumour growth ...
Figure 1 from Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK ...
A, AZD8055/selumetinib synergistically inhibited BRAF and GNAQ mutant ...
Quantitative proteomics profiling reveals activation of mTOR pathway in ...
Adenosine triphosphate-competitive mTOR inhibitors: a new class of ...
Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1 ...
